News

News-Medical.Net on MSN5d
Blood test pinpoints early Alzheimer’s risk with high accuracy
Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...
First blood test for Alzheimer's gets FDA greenlight: 3 things to know
The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...
The American Journal of Managed Care12d
FDA Clears First Blood Test for Early Detection of Alzheimer-Linked Amyloid Plaques
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
Medical Device Network on MSN13d
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
The Scientist11d
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test
The Lumipulse pTau 217/ β-Amyloid 1-42 Plasma Ratio test uses Fujirebio’s fully automated LUMIPULSE® G1200 instrument system, ...
Healio12d
FDA grants 510(k) clearance to in vitro blood-based Alzheimer’s biomarker device
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...
CNN16d
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
It works by measuring two proteins in blood plasma: pTau217 and beta-amyloid 1-42. A ratio of those proteins tends to correlate with the occurrence or absence of amyloid plaques in the brain ...
The New England Journal of Medicine7mon
Plasma Amino Acid Levels and Insulin Secretion in Obesity
The concentration ... 0.05 but less than 0.1). Blood glucose levels differed significantly only at 120 minutes (p less than 0.05). A circadian periodicity of plasma amino acid levels has recently ...